【摘 要】
:
The identification of mechanisms that regulate proliferation and survival of tumor cells is leading to the development of novel therapeutic approaches.To date, several agents specific for molecular ta
【机 构】
:
Alexandria school of Medicine Egypt
【出 处】
:
(BITs 3rd Annual World Cancer Congress-2010, Breast Cancer C
论文部分内容阅读
The identification of mechanisms that regulate proliferation and survival of tumor cells is leading to the development of novel therapeutic approaches.To date, several agents specific for molecular targets amplified or over expressed in cancer cells have been generated.Owing to their high selectivity, these drugs generally have fewer side effects as compared with most conventional chemotherapeutic agents, and can be combined with conventional therapies to improve the response to treatment without a major increase in side effects.It might be argued that target-based agents are active when their targets play a key role in tumor growth, such as ErbB-2 in breast tumors that over express this receptor.However, it must be emphasized that the majority of ErbB-2 positive patients have mechanisms of resistance to trastuzumab at diagnosis.In fact, only 30% of patients with advanced ErbB-2-positive breast cancer respond to trastuzumab as first-line therapy, and the response rate drops to 15% in pretreated patients.Furthermore, almost all patients will become resistant to the drug during the course of the treatment.Therefore, the main question that we need to address in order to improve this therapeutic approach is why tumors do not respond to target-based agents.
其他文献
SLN biopsy has been widely adopted as a safe and accurate means of staging the axilla in patients with breast cancer.Recently it has been shown that SLN can be identified pre operatively using a sub a
The widespread use of monographic screening and ultrasound to detect breast lesions has resulted in a steady increase in the number of non-palpable lesions found.The main problem with these lesions is
Although F-18-Fluorodeoxyglucose (F-18-FDG) Positron Emission Tomography (PET) is a useful tool for the management of the cancer patient, it is not ideal.Several promising clinical and preclinical stu
Regular physical examination is recommended in follow up guidelines for breast cancer patients.The objective of this study is to assess the contribution of physical examination in addition to mammogra
Background: The NHS Cancer Screening Programmes in the U.K is committed to ensuring women receive sufficient and accurate information to make informed choices on screening.Information about the progra
A community based study was conducted during 2008-09 amongst women employees from various offices of Delhi.A total of 424 women who volunteered to participate in the study were trained in the techniqu
Background: Systematic reviews have found that LH-RH agonists are effective in the treatment of premenopausal women with early breast cancer.In an extended phase Ⅱ study, 180 premenopausal women with
Background: PDGF-C has been described in tumor associated fibroblasts, yet little is known about its expression in human breast cancer.Methods: We have generated and characterized a monoclonal antibod
Cellular signalling plays a central role in cancer biology.Many oncogenes and tumor suppressor target the functions of signalling networks underlying cancer malignant phenotype.The reverse phase prote
HER2 (human epidermal growth factor receptor 2) is an important biomarker whose status plays a pivotal role in therapeutic decision making for patients with breast cancer and in determining their clin